Analysis of Human to Human Transmission of Middle East Respiratory Syndrom Coronavirus (MER-CoV)
NCT02605109 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2016-09-01
Summary
This study aimed to analysis the characteristics of MERS transmission and the effect of our institutional personal protective equipment on the controlling the MERS at a tertiary Korean Hospital.
Conditions
Interventions
- OTHER
-
Risk of MERS infection
HCPs, patients and layperson to closely or indirectly contact a case-patients
Sponsors & Collaborators
-
Konkuk University Medical Center
lead OTHER
Principal Investigators
-
Hyun Kyun Ki, MD · Devision of Infection, Department of Medicine, School of Medicine, Konkuk University, Seoul 143-729, Korea
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-06-30
- Primary Completion
- 2015-11-30
- Completion
- 2015-11-30
More Related Trials
-
A Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 Fixed Dose Combination (FDC) in Subjects With Chronic Hepatitis C Genotype 1
NCT02170727 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Study on the Feasibility of Systematic Hepatitis C Screening of Hospitalized Patients
NCT04405024 ·Status: SUSPENDED ·Phase: NA
-
Prevention of Transmission of Hepatitis C Virus (HCV) From HCV-Viremic Organ Donor
NCT04596475 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety, Pharmacokinetics, and Pharmacodynamics of MK-8876 in Participants With Hepatitis C Infection (MK-8876-003)
NCT01930058 ·Status: COMPLETED ·Phase: PHASE1
-
Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination in Treatment-Naïve Hepatitis C Virus Participants (MK-5172-067)
NCT02251990 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Hepatic Responses in Patients Receiving Direct-acting Anti-HCV Drugs
NCT02532907 ·Status: COMPLETED
-
Efficacy and Effectiveness of PegInterferon and Ribavirin in Korean Patients With Chronic Hepatitis C
NCT01596517 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-Infection
NCT03222583 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Pharmacokinetics, and Pharmacodynamics of MK-6325 in Hepatitis C Virus (HCV) Infections (MK-6325-003)
NCT01329913 ·Status: COMPLETED ·Phase: PHASE1
-
Drug Use-Results Survey in Participants Infected With Hepatitis C Virus Genotype 2
NCT02945228 ·Status: COMPLETED
-
Neutrino Regimen for Treatment-experienced HCV GT1 Patients
NCT02480686 ·Status: COMPLETED ·Phase: PHASE4
-
Intravenous Interferon During Liver Transplant
NCT01192698 ·Status: COMPLETED ·Phase: NA
-
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Low-Dose Ribavirin QD in Subjects With Genotype 1a Chronic Hepatitis C Virus Infection
NCT02609659 ·Status: COMPLETED ·Phase: PHASE3
-
Control and Elimination Within Australia of Hepatitis C From People Living With HIV
NCT02102451 ·Status: UNKNOWN
-
Study the Safety and Effectiveness of MK7009 in Hepatitis C Infected Patients (MK-7009-004)(COMPLETED)
NCT00518622 ·Status: COMPLETED ·Phase: PHASE1
-
ABT-450/Ritonavir/ ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-Administered With Ribavirin (RBV) in Treatment Naïve and Treatment Experienced Asian Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Compensated Cirrhosis
NCT02517528 ·Status: COMPLETED ·Phase: PHASE3
-
HCV Treatment in HIV Co-Infected Patients in Asia
NCT01838772 ·Status: COMPLETED ·Phase: PHASE4
-
Drug Use-results Survey in Patients Infected With Hepatitis C Virus Genotype 1
NCT02629172 ·Status: COMPLETED
-
Switching Regimen in Treating Cirrhotic HCV GT1b Subjects
NCT02583685 ·Status: COMPLETED ·Phase: PHASE2
-
Immune Response to Hepatitis C Virus
NCT00006301 ·Status: COMPLETED
-
A Multicenter Phase 3 Study of Interferon-beta-1a for the Treatment of Chronic Hepatitis C in Asian Subjects
NCT00249860 ·Status: COMPLETED ·Phase: PHASE3
-
Simplification and Test and Treat Strategies Towards Hepatitis C Eliminationplatform" in China(STAT)
NCT05906459 ·Status: UNKNOWN
-
A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
NCT02219490 ·Status: COMPLETED ·Phase: PHASE3
-
Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Genotype 4 (GT4) Hepatitis C Virus (HCV) in Egypt
NCT02247401 ·Status: COMPLETED ·Phase: PHASE3
-
Methacetin Breath Test in HCV Patients With Normal and Near-Normal ALT
NCT00294489 ·Status: UNKNOWN